Pediatric atopic dermatitis shows distinct blood proteomic signature

  • Brunner PM & al.
  • J Am Acad Dermatol
  • 19 Apr 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Children with early atopic dermatitis (AD) exhibit a blood proteomic signature of systemic inflammation that is distinct from adult patients.

Why this matters

  • Little is known regarding systemic inflammation in early pediatric AD; this study suggests a need for early intervention.

Key results

  • Levels of Th2 (CCL13, CCL22) and Th17 (PI3/elafin) markers were most strongly increased in pediatric AD blood compared with controls.
  • These markers were distinct from adult patients with AD.
    • Early-onset pediatric AD had a smaller set of upregulated proteins (n=22) compared with adults with longstanding AD (n=61).
    • Only 3 proteins (CCL13, MMP10, and TGF-α) were upregulated in both pediatric and adult AD.
  • Levels of the soluble cytokine receptors ST2 (IL1RL1) and IL1RL2 were correlated with clinical severity, whereas Th1-associated markers IFN-γ, CXCL11, and CCL2 (MCP-1) were inversely correlated with clinical severity.

Study design

  • 30 children
  • Funding: Galderma S.A.; NIH; Pfizer; Northwestern Skin Disease Research Center; Northwestern University Clinical and Translational Sciences Institute.

Limitations

  • Proteins showed different baseline expression in healthy pediatric vs adult samples.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit